# Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism

> **NCT00960544** · PHASE2 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT00960544
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Principal Investigator departed from institution
- **Last updated:** 2019-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00960544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00960544, "Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00960544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*